Abstract |
|
Authors | Liza C Villaruz, Mark A Socinski |
Journal | Current oncology reports
(Curr Oncol Rep)
Vol. 17
Issue 6
Pg. 26
(Jun 2015)
ISSN: 1534-6269 [Electronic] United States |
PMID | 25947099
(Publication Type: Journal Article, Review)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Protein Kinase Inhibitors
- Recombinant Fusion Proteins
- Vascular Endothelial Growth Factor A
- aflibercept
- Bevacizumab
- ramucirumab
- Receptors, Vascular Endothelial Growth Factor
|
Topics |
- Angiogenesis Inhibitors
(therapeutic use)
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
(therapeutic use)
- Bevacizumab
(therapeutic use)
- Carcinoma, Non-Small-Cell Lung
(blood supply, drug therapy)
- Disease-Free Survival
- Humans
- Lung Neoplasms
(blood supply, drug therapy)
- Molecular Targeted Therapy
(methods)
- Neovascularization, Pathologic
(drug therapy)
- Protein Kinase Inhibitors
(therapeutic use)
- Receptors, Vascular Endothelial Growth Factor
(therapeutic use)
- Recombinant Fusion Proteins
(therapeutic use)
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
|